Operose Advisors’s Balchem Corp BCPC Stock Holding History

Operose Advisors’s Portfolio BCPC Stock Details BCPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-248	Closed	-$30.8K	–	746
2023 Q3	$30.8K	Buy	+248	New	+$33K	0.01%	399

Other funds holding BCPC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Operose Advisors's BCPC Position: Q4 2023 in Review

Operose Advisors sold out of Balchem Corp (BCPC) in Q4 2023, closing a stake of 248 shares — an estimated $30.8K sold.

Operose Advisors first reported a position in BCPC in Q3 2023 and held it in 1 quarter. The position peaked at $30.8K in Q3 2023. 292 funds tracked by Wall St. Rank hold BCPC as of Q4 2023.

Operose Advisors reported no remaining Balchem Corp position as of Q4 2023 after selling out during the quarter.
Operose Advisors sold 248 Balchem Corp shares in Q4 2023, an estimated $30.8K.
Operose Advisors first reported a position in Balchem Corp in Q3 2023 and held it in 1 quarter.
Operose Advisors's Balchem Corp position peaked at $30.8K in Q3 2023.
292 funds tracked by Wall St. Rank held Balchem Corp as of Q4 2023.

Based on Operose Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.